RheumMadness Podcast

Mar 25 2025 45 ep. 28 mins 4
RheumMadness Podcast artwork

The RheumMadness podcast is part of a rheumatology learning initiative sponsored by the Rheumatology Research Foundation Clinician Scholar Educator (CSE) Award. Go to https://sites.duke.edu/rheummadness/ to learn more. RheumMadness is created by David Leverenz, MD, who is the recipient of the CSE award. Dr. Leverenz has also received grant funding from Pfizer for quality improvement work unrelated to RheumMadness.

  Education
RSS feed Share
Copy RSS


Subscribe on Podcast Addict


5.13 Submit Those Brackets!

Mar 25 2025 2 mins  
Reminder to Submit your brackets by March 31, 2025 at 11:59pm ET! Link to the RheumMadness OnePager by Dr. Mithu Maheswaranathan (@MithuRheum) To learn more about RheumMadness: https://sites.duke.edu/rheummadness/ Subscribe to our newsletter: https://lists.duke.edu/sympa/subscribe/rheummadness Find us on social media: Bluesky: @rheummadness.bsky.social Instagram: https://www.instag

5.12 Bracketology

Mar 18 2025 26 mins  
In this episode, the RheumMadness leadership team discusses our approach to RheumMadness bracketology, including our favorites, dark horses, and read on the Blue Ribbon Panel. Submit your brackets by March 31, 2025 at 11:59pm ET! To learn more about RheumMadness: https://sites.duke.edu/rheummadness/ Subscribe to our newsletter: https://lists.duke.edu/sympa/subscribe/rheummadness Fi

5.11 More Panelists Plus CAR-Ts in NephMadness

Mar 11 2025 54 mins  
In this episode, we introduce the rest of the Blue Ribbon Panel and interview our friends from NephMadness about their CAR-T region. Remember, RheumMadness brackets are open through March 31 at 11:59pm ET! Submit your brackets here. First time playing RheumMadness? Check out our new explainer video! Blue Ribbon Panelists in this episode: Anastasiya (Stacy) Bagrova, MD completed int

5.10 The Blue Ribbon Panel

Mar 04 2025 33 mins  
In this episode, we introduce 2 of our fantastic Blue Ribbon Panel members. Their full bios are listed below. You'll meet the rest of the panel in the next episode! Also, RheumMadness brackets are open through March 31 at 11:59pm ET! Submit your brackets here. First time playing RheumMadness? Check out our new explainer video! Panelists in this podcast: Michele Meltzer, MD, MBE, is

5.9 B-Cell Breakaway Part 2

Feb 25 2025 29 mins  
In this episode we are joined by some amazing collaborators from the EMEUNET to talk about the STRAP trials. Links to the B-Cell Breakaway Scouting Reports: Obinutuzumab in lupus nephritis, by the University of Michigan Adult Rheumatology Fellowship ProgramCD-19 CAR T-cell therapy, by the Vanderbilt University Adult Rheumatology Fellowship ProgramSTRAP trial, by the Emerging EULAR

5.8 B-Cell Breakaway

Feb 18 2025 48 mins  
In this episode we discuss obinutuzumab for lupus nephritis and anti-CD19 CAR T Cell therapy for autoimmune rheumatic disease. Links to the B-Cell Breakaway Scouting Reports: Obinutuzumab in lupus nephritis, by the University of Michigan Adult Rheumatology Fellowship ProgramCD-19 CAR T-cell therapy, by the Vanderbilt University Adult Rheumatology Fellowship ProgramSTRAP trial, by t

5.7 Full Court Care Champions Part 2

Feb 11 2025 17 mins  
In this episode we present part 2 of our conversation about the teams in the Full Court Care Champions region of RheumMadness 2025! Links to the Full Court Care Champions Scouting Reports: Cost-effectiveness of hydroxychloroquine retinopathy screening, by residents from the Lankenau Medical Center Internal Medicine Residency ProgramSteroid dose in lupus nephritis, by the Washington

5.6 Full Court Care Champions

Feb 04 2025 31 mins  
In this episode we dive into the teams in the Full Court Care Champions region of RheumMadness 2025! Links to the Full Court Care Champions Scouting Reports: Cost-effectiveness of hydroxychloroquine retinopathy screening, by residents from the Lankenau Medical Center Internal Medicine Residency ProgramSteroid dose in lupus nephritis, by the Washington University in St. Louis (WUSTL

5.5 Cytokine Crushers Part 2

Jan 28 2025 29 mins  
This episode contains part 2 of our conversation with Michael Macklin, MD, PharmD, Assistant Professor of Medicine at the University of Chicago, about the Cytokine Crushers region of RheumMadness 2025. In this episode, we focus specifically on the TYK2 in SLE and Oral Anti-IL23 teams. Links to the Cytokine Crushers Scouting Reports: Oral anti-IL23, by collaborating Chicago area rhe

5.4 Cytokine Crushers

Jan 21 2025 36 mins  
In this episode, we are joined by Michael Macklin, MD, PharmD, Assistant Professor of Medicine at the University of Chicago, to discuss the teams in the Cytokine Crushers region of RheumMadness 2025, the Innovation Invitational. This is part 1 of the conversation, where we go in depth about the long-term outcomes of anifrolumab in SLE study and give a primer about type 1/2 cytokine